{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T18:25:36Z","timestamp":1762107936645,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019260","name":"Ag\u00eancia Nacional de Vigil\u00e2ncia Sanit\u00e1ria","doi-asserted-by":"publisher","award":["25000.162707\/2020-91"],"award-info":[{"award-number":["25000.162707\/2020-91"]}],"id":[{"id":"10.13039\/501100019260","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022429","name":"American Fisheries Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006506","name":"Minist\u00e9rio da Sa\u00fade","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006506","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.cellimm.2023.104795","type":"journal-article","created":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T10:14:44Z","timestamp":1702203284000},"page":"104795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Development of a highly cytotoxic, clinical-grade virus-specific T cell product for adoptive T cell therapy"],"prefix":"10.1016","volume":"395-396","author":[{"given":"Fernanda Agostini","family":"Rocha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caio Raony Farina","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anc\u00e9ly Ferreira","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Carolina Buzzo","family":"Stefanini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson","family":"Hamerschlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3890-0827","authenticated-orcid":false,"given":"Luciana Cavalheiro","family":"Marti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2023.104795_b0005","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1182\/blood.V95.7.2240","article-title":"Increased transplant-related morbidity and mortality in CMV-seropositive patients despite highly effective prevention of CMV disease after allogeneic T-cell\u2013 depleted stem cell transplantation","volume":"95","author":"Broers","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cellimm.2023.104795_b0010","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1093\/ajhp\/62.suppl_1.S7","article-title":"Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients","volume":"62","author":"Razonable","year":"2005","journal-title":"Am. J. Health-Syst. Pharm. Ajhp off. J. Am. Soc. Health-Syst. Pharm."},{"issue":"9","key":"10.1016\/j.cellimm.2023.104795_b0015","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.bmt.1705140","article-title":"Cause of death after allogeneic hematopoietic stem cell transplantation (HSCT) in early leukaemias: An EBMT analysis of lethal infectious complications and changes over calendar time","volume":"36","author":"Gratwohl","year":"2005","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.cellimm.2023.104795_b0020","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1399-3062.2009.00411.x","article-title":"Outcome of treatment of Epstein-Barr virus-related posttransplant lymphoproliferative disorder in hematopoietic stem cell recipients: A comprehensive review of reported cases","volume":"11","author":"Styczynski","year":"2009","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.cellimm.2023.104795_b0025","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/bmt.2013.235","article-title":"High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"49","author":"Gilis","year":"2014","journal-title":"Bone Marrow Transplant."},{"issue":"7","key":"10.1016\/j.cellimm.2023.104795_b0030","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jcyt.2014.02.010","article-title":"The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation: Implications for preventative treatment approaches","volume":"16","author":"Jain","year":"2014","journal-title":"Cytotherapy"},{"issue":"6","key":"10.1016\/j.cellimm.2023.104795_b0035","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/infdis\/156.6.899","article-title":"Immunosuppressive effects of ganciclovir on in vitro lymphocyte responses","volume":"156","author":"Bowden","year":"1987","journal-title":"J Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.cellimm.2023.104795_b0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1034\/j.1399-3062.2001.00004.x","article-title":"Cytomegalovirus drug resistance and clinical implications","volume":"3","author":"Chou","year":"2001","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.cellimm.2023.104795_b0045","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1182\/blood.V99.11.3916","article-title":"Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy","volume":"99","author":"Einsele","year":"2002","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.cellimm.2023.104795_b0050","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.bbmt.2007.03.009","article-title":"Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesis","volume":"13","author":"Battiwalla","year":"2007","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.cellimm.2023.104795_b0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/cid\/ciq042","article-title":"Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation","volume":"52","author":"Peggs","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"10","key":"10.1016\/j.cellimm.2023.104795_b0060","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nm1475","article-title":"Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals","volume":"12","author":"Leen","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2023.104795_b0065","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.blre.2017.01.002","article-title":"The clinical impact of cytomegalovirus infection following allogeneic hematopoietic cell transplantation: why the quest for meaningful prophylaxis still matters","volume":"31","author":"Chan","year":"2017","journal-title":"Blood Rev."},{"issue":"31","key":"10.1016\/j.cellimm.2023.104795_b0070","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2017.73.0655","article-title":"Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation","volume":"35","author":"Tzannou","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.cellimm.2023.104795_b0075","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2141.2006.06386.x","article-title":"Capture and generation of adenovirus specific T cells for adoptive immunotherapy","volume":"136","author":"Chatziandreou","year":"2007","journal-title":"Br. J. Haematol."},{"issue":"8","key":"10.1016\/j.cellimm.2023.104795_b0080","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/mt.2012.130","article-title":"Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections","volume":"20","author":"Gerdemann","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cellimm.2023.104795_b0085","doi-asserted-by":"crossref","unstructured":"MA, Wilkie GM, Robinson N, Rivera N, Haque T, Crawford DH, Barry J, Fraser N, Turner DM, Robertson V, Dyer P, Flanagan P, Newlands HR, Campbell J, Turner ML. Establishment and operation of a Good Manufacturing Practice-compliant allogeneic Epstein-Barr virus (EBV)-specific cytotoxic cell bank for the treatment of EBV-associated lymphoproliferative disease. Br J Haematol. 2014 Nov;167(3):402-10.","DOI":"10.1111\/bjh.13051"},{"issue":"3","key":"10.1016\/j.cellimm.2023.104795_b0090","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0163-7258(03)00034-2","article-title":"The human cytomegalovirus","volume":"98","author":"Landolfo","year":"2003","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.cellimm.2023.104795_b0095","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jcv.2007.10.016","article-title":"A fingerprint left by cytomegalovirus infection in the human T cell compartment","volume":"41","author":"van de Berg","year":"2008","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.cellimm.2023.104795_b0100","doi-asserted-by":"crossref","first-page":"e0151965","DOI":"10.1371\/journal.pone.0151965","article-title":"Impact of persistent cytomegalovirus infection on dynamic changes in human immune system profile","volume":"11","author":"Vescovini","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.cellimm.2023.104795_b0105","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1111\/j.1537-2995.2006.01033.x","article-title":"A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers","volume":"46","author":"Dietz","year":"2006","journal-title":"Transfusion"},{"key":"10.1016\/j.cellimm.2023.104795_b0110","doi-asserted-by":"crossref","unstructured":"Dzik WH and Szczepiorkowski ZM, Chapter 26 - Leukocyte-Reduced Products, Editor(s): Christopher D. Hillyer, Leslie E. Silberstein, Paul M. Ness, Kenneth C. Anderson, John D. Roback, Blood Banking and Transfusion Medicine (Second Edition), Churchill Livingstone, 2007, Pages 359-382, ISBN 9780443069819.","DOI":"10.1016\/B978-0-443-06981-9.50031-4"},{"issue":"1","key":"10.1016\/j.cellimm.2023.104795_b0115","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jcyt.2020.08.006","article-title":"Identification of new cytokine combinations for antigen-specific T-cell therapy products via a high-throughput multi-parameter assay","volume":"23","author":"Lazarski","year":"2021","journal-title":"Cytotherapy"},{"issue":"11","key":"10.1016\/j.cellimm.2023.104795_b0120","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1128\/jvi.70.11.7569-7579.1996","article-title":"The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL","volume":"70","author":"Wills","year":"1996","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.cellimm.2023.104795_b0125","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1182\/blood-2005-10-006536","article-title":"In vitro priming and expansion of cytomegalovirus-specific Th1 and Tc1 T cells from naive cord blood lymphocytes","volume":"108","author":"Park","year":"2006","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.cellimm.2023.104795_b0130","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1158\/0008-5472.CAN-09-2860","article-title":"Interleukin-7 permits Th1\/Tc1 maturation and promotes ex vivo expansion of cord blood T cells: a critical step toward adoptive immunotherapy after cord blood transplantation","volume":"70","author":"Davis","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2023.104795_b0135","unstructured":"Cytiva. The stimulation and expansion of antigen specific T cells in a single closed environment using the Xuri\u2122 Cell Expansion System [Online]. Available: https:\/\/cdn.cytivalifesciences.com\/api\/public\/content\/digi-17855-pdf (Accessed October 10, 2023)."},{"key":"10.1016\/j.cellimm.2023.104795_b0140","doi-asserted-by":"crossref","unstructured":"Smith T. A. \u201cCAR-T Cell Expansion in a Xuri Cell Expansion System W25,\u201d in Chimeric Antigen Receptor T Cells: Development and Production. Editors Swiech K., Malmegrim K. C. R., Pican\u00e7o-Castro. V. (New York, NY: Springer US). 2020; 151\u2013163. 10.1007\/978-1-0716-0146-4_11.","DOI":"10.1007\/978-1-0716-0146-4_11"},{"issue":"3","key":"10.1016\/j.cellimm.2023.104795_b0145","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/cancers8030036","article-title":"Different Subsets of T Cells, Memory, Effector Functions, and CAR-T Immunotherapy","volume":"8","author":"Golubovskaya","year":"2016","journal-title":"Cancers (basel)."},{"issue":"8","key":"10.1016\/j.cellimm.2023.104795_b0150","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S0301-472X(03)00160-7","article-title":"Coexistent na\u00efve phenotype and higher cycling rate of cord blood T cells as compared to adult peripheral blood","volume":"31","author":"Szabolcs","year":"2003","journal-title":"Exp. Hematol."},{"issue":"8","key":"10.1016\/j.cellimm.2023.104795_b0155","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1182\/blood.2022016202","article-title":"Banking on virus-specific T cells to fulfill the need for off-the-shelf cell therapies","volume":"141","author":"Quach","year":"2023","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cellimm.2023.104795_b0160","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003461","article-title":"Large-scale manufacturing and characterization of CMV-CD19CAR T cells","volume":"10","author":"Wang","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.cellimm.2023.104795_b0165","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/imj.14462","article-title":"New advances in the management of cytomegalovirus in allogeneic haemopoietic stem cell transplantation","volume":"50","author":"Yong","year":"2020","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.cellimm.2023.104795_b0170","unstructured":"Myers DJ, Collins RA. Blood Donation. Book. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.. PMID: 30247842.24."},{"issue":"5","key":"10.1016\/j.cellimm.2023.104795_b0175","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1111\/trf.15287","article-title":"Effects of starting cellular material composition on chimeric antigen receptor T-cell expansion and characteristics","volume":"59","author":"Elavia","year":"2019","journal-title":"Transfusion"},{"key":"10.1016\/j.cellimm.2023.104795_b0180","first-page":"26","article-title":"Investigation of the Impact from IL-2, IL-7, and IL-15 on the Growth and Signaling of Activated CD4+ T Cells","volume":"21(21), 7814","author":"Coppola","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"747324","key":"10.1016\/j.cellimm.2023.104795_b0185","first-page":"27","article-title":"Interleukin-7 Biology and Its Effects on Immune Cells: Mediator of Generation, Differentiation","volume":"2","author":"Chen","year":"2021","journal-title":"Survival, and Homeostasis. Front Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2023.104795_b0190","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/3877","article-title":"Defective IL7R expression in T(-) B(+) NK(+) severe combined immunodeficiency","volume":"20","author":"Puel","year":"1998","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.cellimm.2023.104795_b0195","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.1007\/s00262-021-02947-y","article-title":"IL-7 coupled with IL-12 increases intratumoral T cell clonality, leading to complete regression of non-immunogenic tumors","volume":"70","author":"Tasaki","year":"2021","journal-title":"Cancer Immunol. Immunother."},{"issue":"7","key":"10.1016\/j.cellimm.2023.104795_b0200","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.4049\/jimmunol.0902593","article-title":"IL-7 is essential for homeostatic control of T cell metabolism in vivo","volume":"184","author":"Jacobs","year":"2010","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.cellimm.2023.104795_b0205","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.immuni.2008.11.002","article-title":"Homeostasis of naive and memory T cells","volume":"29","author":"Surh","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.cellimm.2023.104795_b0210","doi-asserted-by":"crossref","unstructured":"Kotton CN, Torre-Cisneros J; International CMV Symposium Faculty; Aguado JM, Alain S, Baldanti F, et al. Cytomegalovirus in the transplant setting: Where are we now and what happens next? A report from the International CMV Symposium 2021. Transpl Infect Dis. 2022; 24(6): e13977.","DOI":"10.1111\/tid.13977"},{"issue":"4","key":"10.1016\/j.cellimm.2023.104795_b0215","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41423-021-00829-y","article-title":"Comparable anti-CMV responses of transplant donor and third-party CMV-specific T cells for treatment of CMV infection after allogeneic stem cell transplantation","volume":"19","author":"Pei","year":"2022","journal-title":"Cell Mol. Immunol."},{"issue":"135\u2013142","key":"10.1016\/j.cellimm.2023.104795_b0220","first-page":"34","article-title":"Recipient nonhematopoietic antigen-presenting cells are sufficient to induce lethal acute graft-versus-host disease","volume":"18","author":"Koyama","year":"2011","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.cellimm.2023.104795_b0225","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4049\/jimmunol.2000054","article-title":"Early T cell activation metrics predict graft-versus-host disease in a humanized mouse model of hematopoietic stem cell transplantation","volume":"205","author":"Hess","year":"2020","journal-title":"J. Immunol."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000887492300134X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000887492300134X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T18:23:58Z","timestamp":1762107838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000887492300134X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":45,"alternative-id":["S000887492300134X"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2023.104795","relation":{},"ISSN":["0008-8749"],"issn-type":[{"type":"print","value":"0008-8749"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a highly cytotoxic, clinical-grade virus-specific T cell product for adoptive T cell therapy","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2023.104795","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104795"}}